Altekruse SF, McGlynn KA, Dickie LA, Kleiner DE. Hepatocellular Carcinoma Confirmation, Treatment, and Survival in Surveillance, Epidemiology, and End Results Registries, 1992–2008. Hepatology. 2012;55(2):476–82.
Kitisin K, Packiam V, Steel J, Humar A, Gamblin TC, Geller DA, et al. Presentation and outcomes of hepatocellular carcinoma patients at a western centre. HPB. 2011;13(10):712–22.
Article PubMed PubMed Central Google Scholar
Rastogi A. Changing role of histopathology in the diagnosis and management of hepatocellular carcinoma. World J Gastroenterol. 2018;24(35):4000–13.
Article PubMed PubMed Central Google Scholar
Tommaso LD, Spadaccini M, Donadon M, Personeni N, Elamin A, Aghemo A, et al. Role of liver biopsy in hepatocellular carcinoma. World J Gastroenterol. 2019;25(40):6041–52.
Article PubMed PubMed Central Google Scholar
Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, et al. Hepatocellular carcinoma. Nature Reviews Disease Primers. 2021;7(1):6.
Ho CL, Yu SC, Yeung DW. 11C-acetate PET imaging in hepatocellular carcinoma and other liver masses. J Nucl Med. 2003;44(2):213–21.
Park S, Kim T-S, Kang SH, Kim HB, Park J-W, Kim S-k. 11C-acetate and 18F-fluorodeoxyglucose positron emission tomography/computed tomography dual imaging for the prediction of response and prognosis after transarterial chemoembolization. Medicine. 2018;97(37):e12311.
Article PubMed PubMed Central Google Scholar
Larsson P, Arvidsson D, Bjornstedt M, Isaksson B, Jersenius U, Motarjemi H, et al. Adding 11C-acetate to 18F-FDG at PET Examination Has an Incremental Value in the Diagnosis of Hepatocellular Carcinoma. Mol Imaging Radionucl Ther. 2012;21(1):6–12.
Article PubMed PubMed Central Google Scholar
Park J-W, Kim JH, Kim SK, Kang KW, Park KW, Choi J-I, et al. A Prospective Evaluation of 18F-FDG and 11C-Acetate PET/CT for Detection of Primary and Metastatic Hepatocellular Carcinoma. J Nucl Med. 2008;49(12):1912–21.
Gao X, Lin S-H, Ren F, Li J-T, Chen J-J, Yao C-B, et al. Acetate functions as an epigenetic metabolite to promote lipid synthesis under hypoxia. Nat Commun. 2016;7(1):11960.
Article CAS PubMed PubMed Central Google Scholar
Yang X, Yeung WHO, Tan KV, Ng TPK, Pang Li, Zhou J, et al. Development of cisplatin-loaded hydrogels for trans-portal vein chemoembolization in an orthotopic liver cancer mouse model. Drug Delivery. 2021;28(1):520–9.
Article CAS PubMed PubMed Central Google Scholar
Tan KV, Yang X, Chan CY, Shi J, Chang H-C, Chiu KW-H, et al. Non-invasive PET/MR Imaging in an Orthotopic Mouse Model of Hepatocellular Carcinoma. J Vis Exp. 2022;(186):63958. https://doi.org/10.3791/63958.
Liao Y, Smyth GK, Shi W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2013;30(7):923–30.
Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biology. 2014;15(12):550.
Article PubMed PubMed Central Google Scholar
Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci. 2005;102(43):15545–50.
Article CAS PubMed PubMed Central Google Scholar
Goldman MJ, Craft B, Hastie M, Repečka K, McDade F, Kamath A, et al. Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol. 2020;38(6):675–8.
Article CAS PubMed PubMed Central Google Scholar
Tan P, Hoshida Y. Nearest Template Prediction: A Single-Sample-Based Flexible Class Prediction with Confidence Assessment. PLoS ONE. 2010;5(11):e15543.
Hänzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-Seq data. BMC Bioinformatics. 2013;14(1):7.
Article PubMed PubMed Central Google Scholar
Lu R-C, She B, Gao W-T, Ji Y-H, Xu D-D, Wang Q-S, et al. Positron-emission tomography for hepatocellular carcinoma: Current status and future prospects. World J Gastroenterol. 2019;25(32):4682–95.
Article CAS PubMed PubMed Central Google Scholar
Koshiji M, Kageyama Y, Pete EA, Horikawa I, Barrett JC, Huang LE. HIF-1α induces cell cycle arrest by functionally counteracting Myc. EMBO J. 2004;23(9):1949–56.
Article CAS PubMed PubMed Central Google Scholar
Lu X, Kang Y. Hypoxia and Hypoxia-Inducible Factors: Master Regulators of Metastasis. Clin Cancer Res. 2010;16(24):5928–35.
Article CAS PubMed PubMed Central Google Scholar
Elvidge GP, Glenny L, Appelhoff RJ, Ratcliffe PJ, Ragoussis J, Gleadle JM. Concordant Regulation of Gene Expression by Hypoxia and 2-Oxoglutarate-dependent Dioxygenase Inhibition. J Biol Chem. 2006;281(22):15215–26.
Article CAS PubMed Google Scholar
van der Pol CB, Lim CS, Sirlin CB, McGrath TA, Salameh J-P, Bashir MR, et al. Accuracy of the Liver Imaging Reporting and Data System in Computed Tomography and Magnetic Resonance Image Analysis of Hepatocellular Carcinoma or Overall Malignancy—A Systematic Review. Gastroenterology. 2019;156(4):976–86.
Erickson B, Kirk S, Lee Y, Bathe O, Kearns M, Gerdes C, et al. Radiology data from the cancer genome atlas liver hepatocellular carcinoma [TCGA-LIHC] collection. The Cancer Imaging Archive. 2016.
Singh PK, Heiden BT, Chen G, Hermann M, Brown RKJ, Orringer MB, et al. 18F-FDG PET intensity correlates with a hypoxic gene signature and other oncogenic abnormalities in operable non-small cell lung cancer. Plos One. 2018;13(7):e0199970.
Yun M, Bang S-H, Kim JW, Park JY, Kim KS, Lee JD. The Importance of Acetyl Coenzyme A Synthetase for 11C-Acetate Uptake and Cell Survival in Hepatocellular Carcinoma. J Nucl Med. 2009;50(8):1222–8.
Article CAS PubMed Google Scholar
Xia H, Chen J, Gao H, Kong SN, Deivasigamani A, Shi M, et al. Hypoxia-induced modulation of glucose transporter expression impacts 18F-fluorodeoxyglucose PET-CT imaging in hepatocellular carcinoma. Eur J Nucl Med Mol Imaging. 2019;47(4):787–97.
Comerford Sarah A, Huang Z, Du X, Wang Y, Cai L, Witkiewicz Agnes K, et al. Acetate Dependence of Tumors. Cell. 2014;159(7):1591–602.
Article CAS PubMed PubMed Central Google Scholar
Zhao J-G, Feng G-S, Kong X-Q, Li X, Li M-H, Cheng Y-S. Assessment of hepatocellular carcinoma vascularity before and after transcatheter arterial chemoembolization by using first pass perfusion weighted MR imaging. World J Gastroenterol. 2004;10(8):1152–6.
Article PubMed PubMed Central Google Scholar
van den Hoff J, Burchert W, Borner AR, Fricke H, Kuhnel G, Meyer GJ, et al. [1-(11)C]Acetate as a quantitative perfusion tracer in myocardial PET. J Nucl Med. 2001;42(8):1174–82.
Liu Z, Tu K, Wang Y, Yao B, Li Q, Wang L, et al. Hypoxia Accelerates Aggressiveness of Hepatocellular Carcinoma Cells Involving Oxidative Stress, Epithelial-Mesenchymal Transition and Non-Canonical Hedgehog Signaling. Cell Physiol Biochem. 2017;44(5):1856–68.
Article CAS PubMed Google Scholar
Reig M, Forner A, Rimola J, Ferrer-Fàbrega J, Burrel M, Garcia-Criado Á, et al. BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update. J Hepatol. 2022;76(3):681–93.
Lopci E, Grassi I, Chiti A, Nanni C, Cicoria G, Toschi L, et al. PET radiopharmaceuticals for imaging of tumor hypoxia: a review of the evidence. Am J Nucl Med Mol Imaging. 2014;4(4):365–84.
PubMed PubMed Central Google Scholar
Marrero JA, Kulik LM, Sirlin CB, Zhu AX, Finn RS, Abecassis MM, et al. Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology. 2018;68(2):723–50.
留言 (0)